risperidone has been researched along with Cognitive Decline in 17 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A double-blind, placebo-controlled study involved 75 patients with schizophrenia who randomly received low dose (100 mg/day) or high dose minocycline (200 mg/day) or placebo added to risperidone." | 9.30 | The effect of minocycline on amelioration of cognitive deficits and pro-inflammatory cytokines levels in patients with schizophrenia. ( Kosten, TR; Wu, R; Zhang, L; Zhang, XY; Zhao, J; Zheng, H, 2019) |
| " This study sought to explore the characteristics of white matter structural networks in chronic never-treated schizophrenia and those treated with clozapine or risperidone, and its potential association with cognitive function." | 7.96 | Characteristics of White Matter Structural Networks in Chronic Schizophrenia Treated With Clozapine or Risperidone and Those Never Treated. ( Gong, Q; Hu, N; Lencer, R; Li, S; Lui, S; Luo, C; Xiao, Y; Zhang, W, 2020) |
| "Schizophrenia is a disorder characterized by cognitive impairment and psychotic symptoms that fluctuate over time and can only be mitigated with the chronic administration of antipsychotics." | 5.72 | Long-lasting rescue of schizophrenia-relevant cognitive impairments via risperidone-loaded microPlates. ( Bellotti, E; Contarini, G; Decuzzi, P; Drago, F; Geraci, F; Leggio, GM; Papaleo, F; Piazza, C; Torrisi, SA, 2022) |
| "A double-blind, placebo-controlled study involved 75 patients with schizophrenia who randomly received low dose (100 mg/day) or high dose minocycline (200 mg/day) or placebo added to risperidone." | 5.30 | The effect of minocycline on amelioration of cognitive deficits and pro-inflammatory cytokines levels in patients with schizophrenia. ( Kosten, TR; Wu, R; Zhang, L; Zhang, XY; Zhao, J; Zheng, H, 2019) |
| " This study sought to explore the characteristics of white matter structural networks in chronic never-treated schizophrenia and those treated with clozapine or risperidone, and its potential association with cognitive function." | 3.96 | Characteristics of White Matter Structural Networks in Chronic Schizophrenia Treated With Clozapine or Risperidone and Those Never Treated. ( Gong, Q; Hu, N; Lencer, R; Li, S; Lui, S; Luo, C; Xiao, Y; Zhang, W, 2020) |
| "Thirty-seven clinically stable participants with schizophrenia or schizoaffective disorder, aged 50 years or greater, and having been treated with olanzapine or risperidone monotherapy at the same dose for at least 6 months." | 3.85 | Cognition and Dopamine D ( Caravaggio, F; Gerretsen, P; Graff-Guerrero, A; Mamo, DC; Mar, W; Mulsant, BH; Nakajima, S; Pollock, BG; Rajji, TK; Suzuki, T; Uchida, H, 2017) |
| "Schizophrenia is a disorder characterized by cognitive impairment and psychotic symptoms that fluctuate over time and can only be mitigated with the chronic administration of antipsychotics." | 1.72 | Long-lasting rescue of schizophrenia-relevant cognitive impairments via risperidone-loaded microPlates. ( Bellotti, E; Contarini, G; Decuzzi, P; Drago, F; Geraci, F; Leggio, GM; Papaleo, F; Piazza, C; Torrisi, SA, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (58.82) | 24.3611 |
| 2020's | 7 (41.18) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, Z | 1 |
| Liu, Q | 1 |
| Zhang, Y | 1 |
| Guan, X | 1 |
| Xiu, M | 1 |
| Zhang, X | 1 |
| Bellotti, E | 1 |
| Contarini, G | 1 |
| Geraci, F | 1 |
| Torrisi, SA | 1 |
| Piazza, C | 1 |
| Drago, F | 1 |
| Leggio, GM | 1 |
| Papaleo, F | 1 |
| Decuzzi, P | 1 |
| Kelle, I | 1 |
| Eriman, H | 1 |
| Erdinc, M | 1 |
| Uyar, E | 1 |
| Nguyen, HD | 1 |
| Jo, WH | 1 |
| Hoang, NHM | 1 |
| Kim, MS | 1 |
| Zhang, L | 1 |
| Zheng, H | 1 |
| Wu, R | 1 |
| Kosten, TR | 1 |
| Zhang, XY | 2 |
| Zhao, J | 1 |
| Ibrahim, I | 1 |
| Tobar, S | 1 |
| Fathi, W | 1 |
| ElSayed, H | 1 |
| Yassein, A | 1 |
| Eissa, A | 1 |
| Elsheshtawy, E | 1 |
| Elboraei, H | 1 |
| Shahda, M | 1 |
| Elwasify, M | 1 |
| Ibrahim, A | 1 |
| Chen, K | 1 |
| Wood, J | 1 |
| Dickerson, F | 1 |
| Yolken, RH | 1 |
| El Chennawi, F | 1 |
| Gur, R | 2 |
| El Bahaey, W | 1 |
| Nimgaonkar, V | 1 |
| Mansour, H | 1 |
| Gurler, D | 1 |
| White, DM | 2 |
| Kraguljac, NV | 2 |
| Ver Hoef, L | 1 |
| Martin, C | 1 |
| Tennant, B | 1 |
| Lahti, AC | 2 |
| Luo, C | 1 |
| Lencer, R | 1 |
| Hu, N | 1 |
| Xiao, Y | 1 |
| Zhang, W | 1 |
| Li, S | 1 |
| Lui, S | 1 |
| Gong, Q | 1 |
| Wu, ZW | 1 |
| Shi, H | 1 |
| Chen, DC | 1 |
| Chen, S | 1 |
| Xiu, MH | 1 |
| Suzuki, H | 1 |
| Hibino, H | 1 |
| Inoue, Y | 1 |
| Mikami, A | 1 |
| Matsumoto, H | 1 |
| Mikami, K | 1 |
| Boccardi, V | 1 |
| Baroni, M | 1 |
| Paolacci, L | 1 |
| Ercolani, S | 1 |
| Longo, A | 1 |
| Giordano, M | 1 |
| Ruggiero, C | 1 |
| Mecocci, P | 1 |
| Rook, JM | 1 |
| Bertron, JL | 1 |
| Cho, HP | 1 |
| Garcia-Barrantes, PM | 1 |
| Moran, SP | 1 |
| Maksymetz, JT | 1 |
| Nance, KD | 1 |
| Dickerson, JW | 1 |
| Remke, DH | 1 |
| Chang, S | 1 |
| Harp, JM | 1 |
| Blobaum, AL | 1 |
| Niswender, CM | 1 |
| Jones, CK | 1 |
| Stauffer, SR | 1 |
| Conn, PJ | 1 |
| Lindsley, CW | 1 |
| Cadena, EJ | 1 |
| Reid, MA | 1 |
| Jindal, R | 1 |
| Pixley, RM | 1 |
| Rajji, TK | 1 |
| Mulsant, BH | 1 |
| Nakajima, S | 1 |
| Caravaggio, F | 1 |
| Suzuki, T | 1 |
| Uchida, H | 1 |
| Gerretsen, P | 1 |
| Mar, W | 1 |
| Pollock, BG | 1 |
| Mamo, DC | 1 |
| Graff-Guerrero, A | 1 |
| Singh, KP | 1 |
| Singh, MK | 1 |
| Park, CH | 1 |
| Park, TW | 1 |
| Yang, JC | 1 |
| Lee, KH | 1 |
| Huang, GB | 1 |
| Tong, Z | 1 |
| Park, MS | 1 |
| Chung, YC | 1 |
| Stone, WS | 1 |
| Hsi, X | 1 |
| Giuliano, AJ | 1 |
| Tan, L | 1 |
| Zhu, S | 1 |
| Li, L | 1 |
| Seidman, LJ | 1 |
| Tsuang, MT | 1 |
5 trials available for risperidone and Cognitive Decline
| Article | Year |
|---|---|
Superoxide Dismutase, BDNF, and Cognitive Improvement in Drug-Naive First-Episode Patients With Schizophrenia: A 12-Week Longitudinal Study.
Topics: Adolescent; Adult; Antioxidants; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; Cognition; | 2022 |
The effect of minocycline on amelioration of cognitive deficits and pro-inflammatory cytokines levels in patients with schizophrenia.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antipsychotic Agents; Cognitive Dysfunction; Double-Bli | 2019 |
Randomized controlled trial of adjunctive Valproate for cognitive remediation in early course schizophrenia.
Topics: Adolescent; Adult; Antimanic Agents; Antipsychotic Agents; Cognitive Dysfunction; Double-Blind Metho | 2019 |
No negative symptoms in healthy volunteers after single doses of amisulpride, aripiprazole, and haloperidol: a double-blind placebo-controlled trial.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Cognitive Dysfunction; Dizziness; Double-Bli | 2012 |
Are neurocognitive, clinical and social dysfunctions in schizotaxia reversible pharmacologically?: Results from the Changsha study.
Topics: Adolescent; Adult; Antipsychotic Agents; China; Cluster Analysis; Cognitive Dysfunction; Double-Blin | 2012 |
12 other studies available for risperidone and Cognitive Decline
| Article | Year |
|---|---|
Long-lasting rescue of schizophrenia-relevant cognitive impairments via risperidone-loaded microPlates.
Topics: Animals; Antipsychotic Agents; Cognitive Dysfunction; Delayed-Action Preparations; Dysbindin; Mice; | 2022 |
Risperidone and ethyl pyruvate have protective effects against ketamine-induced cognitive impairments in mice.
Topics: Animals; Antipsychotic Agents; Cognitive Dysfunction; Ketamine; Mice; Pyruvates; Risperidone | 2022 |
Risperidone ameliorated 1,2-Diacetylbenzene-induced cognitive impairments in mice via activating prolactin signaling pathways.
Topics: Animals; Cognitive Dysfunction; Glycogen Synthase Kinase 3 beta; Mice; MicroRNAs; Prolactin; Risperi | 2023 |
Neural Signatures of Memory Encoding in Schizophrenia Are Modulated by Antipsychotic Treatment.
Topics: Adult; Antipsychotic Agents; Cognitive Dysfunction; Default Mode Network; Female; Glutamic Acid; Glu | 2021 |
Characteristics of White Matter Structural Networks in Chronic Schizophrenia Treated With Clozapine or Risperidone and Those Never Treated.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Clozapine; Cognitive Dysfunction; Diffusion Tensor Ima | 2020 |
BDNF serum levels and cognitive improvement in drug-naive first episode patients with schizophrenia: A prospective 12-week longitudinal study.
Topics: Adult; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; Cognition; Cognition Disorders; Cogn | 2020 |
Benefit of extending the dosing interval of long-acting antipsychotic injections in elderly schizophrenics with cognitive dysfunction.
Topics: Aged; Antipsychotic Agents; Cognitive Dysfunction; Dose-Response Relationship, Drug; Drug Administra | 2017 |
Anticholinergic Burden and Functional Status in Older People with Cognitive Impairment: Results from the Regal Project.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Cholinergic Antagonists; Cog | 2017 |
A Novel M
Topics: Allosteric Regulation; Animals; Antipsychotic Agents; CHO Cells; Cognition; Cognitive Dysfunction; C | 2018 |
Cognitive control network dysconnectivity and response to antipsychotic treatment in schizophrenia.
Topics: Adult; Antipsychotic Agents; Cognitive Dysfunction; Connectome; Executive Function; Female; Follow-U | 2019 |
Cognition and Dopamine D
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Cognitive Dysfunction; Corpus Striatum; Female; Humans; | 2017 |
In utero exposure to atypical antipsychotic drug, risperidone: Effects on fetal neurotoxicity in hippocampal region and cognitive impairment in rat offspring.
Topics: Analysis of Variance; Animals; Animals, Newborn; Antipsychotic Agents; Apoptosis; Avoidance Learning | 2017 |